Nuvation Bio Stock (NYSE: NUVB) stock price, news, charts, stock research, profile.
Open | $3.350 |
Close | $3.250 |
Volume / Avg. | 690.376K / 1.443M |
Day Range | 3.200 - 3.380 |
52 Wk Range | 0.950 - 4.160 |
Market Cap | $801.871M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 60 |
Short Interest | 2.11% |
Days to Cover | 2.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nuvation Bio (NYSE: NUVB) through any online brokerage.
Other companies in Nuvation Bio’s space includes: Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Verona Pharma (NASDAQ:VRNA).
The latest price target for Nuvation Bio (NYSE: NUVB) was reported by RBC Capital on Wednesday, April 17, 2024. The analyst firm set a price target for 5.00 expecting NUVB to rise to within 12 months (a possible 53.85% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Nuvation Bio (NYSE: NUVB) is $3.25 last updated May 10, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Nuvation Bio.
Nuvation Bio’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Nuvation Bio.
Nuvation Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.